The upcoming report from Addus HomeCare (ADUS) is expected to reveal quarterly earnings of $1.71 per share, indicating an increase of 23.9% compared to the year-ago period. Analysts forecast revenues of $369.61 million, representing an increase of 24.4% year over year.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
Given this perspective, it's time to examine the average forecasts of specific Addus HomeCare metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts expect 'Revenue- Personal care' to come in at $282.11 million. The estimate points to a change of +28% from the year-ago quarter.
The combined assessment of analysts suggests that 'Revenue- Home Health' will likely reach $17.37 million. The estimate points to a change of -2.6% from the year-ago quarter.
According to the collective judgment of analysts, 'Revenue- Hospice' should come in at $69.14 million. The estimate suggests a change of +17.2% year over year.
View all Key Company Metrics for Addus HomeCare here>>>
Over the past month, shares of Addus HomeCare have returned +4.2% versus the Zacks S&P 500 composite's -1.3% change. Currently, ADUS carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Addus HomeCare Corporation (ADUS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
